Cocrystal Pharma, Inc. (COCP)

CIK 1412486 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cocrystal Pharma, Inc..

Recent SEC filings

FiledFormAccession number
Sep 9, 20268-K0001493152-26-041877
Aug 21, 202630001493152-26-039674
Aug 18, 20268-K0001493152-26-039023
Aug 17, 20268-K0001493152-26-038747
Aug 13, 202610-Q0001493152-26-037573
Aug 7, 2026SCHEDULE 13D0000944809-26-000002
Aug 7, 2026SCHEDULE 13D/A0001493152-26-036650
Aug 6, 202640001493152-26-036396
Aug 5, 202640001493152-26-036169
Aug 3, 20268-K0001493152-26-035743
Jul 17, 20268-K0001493152-26-033662
Jun 9, 20268-K0001493152-26-027837
Jun 3, 202630001493152-26-027053
Jun 3, 202640001493152-26-027054
Jun 3, 20268-K0001493152-26-026965
May 27, 2026DEF 14A0001493152-26-025428
May 27, 2026DEFA14A0001493152-26-025430
May 26, 20268-K0001493152-26-025172
May 15, 202610-Q0001493152-26-023377
May 1, 2026EFFECT9999999995-26-001445
Apr 30, 20268-K0001493152-26-020586
Apr 23, 2026S-30001493152-26-018732
Apr 2, 20268-K0001493152-26-014819
Mar 31, 20268-K0001493152-26-013837
Mar 31, 202610-K0001493152-26-013838